Ultrasound Assessment of Entheseal Sites and Anterior Chest Wall in Ankylosing Spondylitis: A Cross‐Sectional Study
Journal of Ultrasound in Medicine · 2023
DOI: 10.1002/jum.16287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2023. Verfasst von Haiqin Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, Thoracic Wall. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong High-level hospital construction fund, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Objectives
The study was designed to evaluate entheseal sites and anterior chest wall (ACW) of patients with ankylosing spondylitis (AS) using ultrasound (US) and investigate the correlation between disease activity and US score.
Methods
This prospective cross‐sectional study included 104 patients with AS and 50 control subjects. Each patient underwent US scanning of 23 entheses and 11 sites of the ACW. The US features, including hypoechogenicity, thickness, erosion, calcification, bursitis, and Doppler signal, were evaluated. Disease activity was assessed based on C reactive protein (CRP), erythrocyte sedimentation rate (ESR), disease activity score‐C reactive protein (ASDAS‐CRP), and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
Results
The most commonly involved entheses on US were the Achilles tendon (AT) and quadriceps tendon (QT). The most involved site of ACW was the sternoclavicular joint (SCJ). Compared with the control group, significant differences were observed in the AS group in the rates of US enthesitis and ACW in AT ( P = .01), SCJ ( P = .00), and costochondral joint (CCJ) ( P = .01). Patients with high or very high disease activity had a higher erosion score ( P = .02). The erosion score was weakly positively associated with CRP, ESR, BASDAI, ASDAS‐CRP, and ASDAS‐ESR (correlation coefficient: 0.22–0.45).
Conclusions
The most commonly involved entheseal sites on US were AT and QT, while the site of ACW was SCJ. The US assessment of AS should take the ACW into account. High disease activity might indicate erosion in AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Peking University Shenzhen Hospital, Shenzhen, China.
- Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, Shenzhen, China.
- Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Haiyu Luo
Förderung
- Guangdong High-level hospital construction fund
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzhen
- Science, Technology and Innovation Commission of Shenzhen Municipality in China
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Xie, H., Zhou, G., Luo, H., Zhao, C., Zhang, Y., Dong, Q., Lv, H., Zhong, J., Lv, J., Zhang, W., Sun, D., Wang, Q., & Liu, L. (2023). Ultrasound Assessment of Entheseal Sites and Anterior Chest Wall in Ankylosing Spondylitis: A Cross‐Sectional Study. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16287
Vancouver
Xie H, Zhou G, Luo H, Zhao C, Zhang Y, Dong Q, et al. Ultrasound Assessment of Entheseal Sites and Anterior Chest Wall in Ankylosing Spondylitis: A Cross‐Sectional Study. Journal of Ultrasound in Medicine. 2023. doi:10.1002/jum.16287
BibTeX
@article{Xie2023,
author = {Xie, Haiqin and Zhou, Gengmin and Luo, Haiyu and Zhao, Chenyang and Zhang, Yusen and Dong, Qian and Lv, Heng and Zhong, Jianqiu and Lv, Jiyang and Zhang, Weiwei and Sun, Desheng and Wang, Qingwen and Liu, Li},
title = {Ultrasound Assessment of Entheseal Sites and Anterior Chest Wall in Ankylosing Spondylitis: A Cross‐Sectional Study},
journal = {Journal of Ultrasound in Medicine},
year = {2023},
doi = {10.1002/jum.16287}
}
EUVIMED